Advice

following an abbreviated submission:

testosterone gel (Testim) is accepted for restricted use within NHSScotland as replacement therapy for adult male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

It is an alternative to another formulation of testosterone gel, of the same strength and cost, and is restricted to use as an alternative to testosterone gel patches for those patients requiring a transdermal delivery system. Testosterone is at least as effective as testosterone patches and costs less.

Download detailed advice27KB (PDF)

Download

Medicine details

Medicine name:
testosterone gel (Testim)
SMC ID:
284/06
Indication:
as replacement therapy for adult male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Pharmaceutical company
Ipsen Ltd
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Restricted
Date advice published:
10 July 2006